Obrem Capital Management

Obrem Capital Management is a New York-based investment management firm that operates as a hedge fund. Founded in 2005 by Andrew Vogel, the firm employs a fundamental, value-driven approach to investing across a variety of sectors, including healthcare, technology, and consumer goods. As a financial entity, Obrem focuses on identifying undervalued companies with strong growth catalysts rather than developing its own therapeutic products. The firm typically manages a concentrated portfolio of both public and private equity investments. It is recognized for its deep research capabilities and its role as a capital provider within the life sciences ecosystem. Obrem Capital Management is primarily an investment vehicle and does not conduct laboratory research or clinical trials.